Scientists have discovered what may be the earliest possible biological marker of type 1 diabetes, formerly known as juvenile type 1 diabetes. If their mouse study can be replicated in humans, which they are now attempting to do, the timing of therapeutic intervention may be drastically improved for patients who are on course to develop the disease.